Superbugs' sticky fingers stopped in fight against antibiotic resistance

August 3, 2016

Disarming the superbugs resistant to antibiotics is the Holy Grail in the global fight against a pandemic predicted to kill more people than all cancers combined in the next few decades.

New research has found a way to disarm the infecting superbug, also known as E. coli ST131, rendering it harmless.

Painful urinary tract infections are very common, particularly in women, babies and the elderly. Around one in two women and one in 20 men will get a in their lifetime.

"My research has devised a strategy to stop the superbugs by identifying their essential weapons so they can be blocked and left harmless," says Dr Sohinee Sarkar, a postdoctoral researcher at the Queensland University of Technology's Institute of Health and Biomedical Innovation.

"In this way, we can treat the infection without using antibiotics that can create more and more resistant bacteria."

Dr Geoff Garrett, Queensland's Chief Scientist says it's great to see Queensland's early career researchers tackling such significant health issues.

"Antibiotics are such a great innovation but the rapidly evolving resistance is quite frightening" he says.

Sohinee is one of ten 2016 Queensland Fresh Science finalists and her one minute explanation of her research won the "People's Award" at the Fresh Science public event in Brisbane.

E. coli ST131 superbugs have numerous finger-like projections over their surface, which help them cling to the urinary tract walls and not get washed out when urine passes.

When E. coli ST131 use these fingers to stick to the urinary tract, they can clump together into a 'biofilm' and cause infection. They can also climb up into the kidneys and enter the blood.

"I've found that if we can stop these 'sticky fingers' from working then the E. coli can't form the biofilms that cause infections," Dr Sarkar says.

"This is very exciting as drugs that stop these sticky fingers are already being developed. Work by our group and our collaborators have shown that these drugs can treat acute urinary tract infections in laboratory studies."

The next step are clinical trials, but Dr Sakar is confident that drugs effective against E. coli ST131 will be available sometime within the next 10 years.

"This is a huge step in our war on these superbugs that are becoming more and more resistant to antibiotics," she says.

Explore further: Second US patient identified with super-resistant bacteria

Related Stories

Second US patient identified with super-resistant bacteria

June 28, 2016
A second US patient has been infected with a superbug that is highly resistant to last-resort antibiotics, scientists said Monday.

Antibiotic-resistant strain of E. coli increasing among older adults and residents of nursing homes

March 12, 2013
Antibiotic-resistant Escherichia coli (E. coli) continues to proliferate, driven largely by expansion of a strain of E. coli know as sequence type ST131. A new study points to hospitals and long-term care facilities (LTCF) ...

Antibiotic resistance in children is high and associated with previous antibiotic use

March 15, 2016
Antibiotic resistance in children with urinary infections is high and could render some antibiotics ineffective as first-line treatments, warns a study published by The BMJ today.

Recommended for you

Anti-malaria drug shows promise as Zika virus treatment

November 17, 2017
A new collaborative study led by researchers at Sanford Burnham Prebys Medical Discovery Institute (SBP) and UC San Diego School of Medicine has found that a medication used to prevent and treat malaria may also be effective ...

Decrease in sunshine, increase in Rickets

November 17, 2017
A University of Toronto student and professor have teamed up to discover that Britain's increasing cloudiness during the summer could be an important reason for the mysterious increase in Rickets among British children over ...

Scientists identify biomarkers that indicate likelihood of survival in infected patients

November 17, 2017
Scientists have identified a set of biomarkers that indicate which patients infected with the Ebola virus are most at risk of dying from the disease.

Research team unlocks secrets of Ebola

November 16, 2017
In a comprehensive and complex molecular study of blood samples from Ebola patients in Sierra Leone, published today (Nov. 16, 2017) in Cell Host and Microbe, a scientific team led by the University of Wisconsin-Madison has ...

Study raises possibility of naturally acquired immunity against Zika virus

November 16, 2017
Birth defects in babies born infected with Zika virus remain a major health concern. Now, scientists suggest the possibility that some women in high-risk Zika regions may already be protected and not know it.

A structural clue to attacking malaria's 'Achilles heel'

November 16, 2017
Researchers from The Scripps Research Institute (TSRI) and PATH's Malaria Vaccine Initiative (MVI) have shed light on how the human immune system recognizes the malaria parasite though investigation of antibodies generated ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.